Bo Fishback
Founder and CEO, Zaarly

Bo Fishback is the Founder and CEO of Zaarly. Bo was previously the vice president of entrepreneurship for the Ewing Marion Kauffman Foundation and the president of Kauffman Labs for Enterprise Creation.

He is a founder of Orbis Biosciences, a drug delivery and particle fabrication company whose core intellectual property was developed from research conducted at the University of Illinois at Urbana-Champaign. Fishback also was a co-founder of Lightspeed Genomics, a next-generation genome sequencing company that was spun out of a research program at the Massachusetts Institute of Technology and acquired by Macrogen. Beyond these ventures, he has worked with a variety of life sciences and high-tech startup companies as an advisor, board member, and angel investor. Currently, he is on the board of directors for Orbis Biosciences and is an advisor for Plotwatt, Inc.

Fishback joined the Kauffman Foundation in 2006 as a director in the advancing innovation area, where he studied the country's best business accelerators and university-based commercialization programs. In 2007, he joined Kansas City- based BioMed Valley Discoveries, a translational research and development organization affiliated with the Stowers Institute whose mission is to translate basic biomedical research into applications that improve human health. In addition, Fishback developed the equity simulation tool,, an educational tool aimed at helping founders understand the impact of raising equity financing.

Prior to joining the Kauffman Foundation, he was a consultant with Puretech Ventures in Boston. Before that, he served as a director at IQHealth for Cerner where he led a team of application developers, designers, and product managers in the creation of Web- based health tools.

Fishback received his Bachelor of Science degree in biomedical engineering from Southern Methodist University and earned an MBA from the Harvard Business School.